Search

everythinglearnresearchcommunity

for

Search:↓

Surgical removal of an adrenal tumor resolved hormonal issues in a young woman.

A 20-year-old woman with a rare form of Turner syndrome showed improvement with hormonal therapy and needs comprehensive care.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Children's hair grows in different types from before birth through puberty, with growth rates and characteristics varying by age, sex, and race.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Finasteride safely reduces excessive hair growth in women.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Lower growth factors linked to balding in androgenetic alopecia.

Young women with PCOS and no other heart risk factors have normal heart function.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Certain treatments can speed up local hair growth in mice but don't change the overall hair growth pattern.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.